Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yongping Song

Showing results (141-150 of 252) with videos related to

Pageof 26
Sort By:
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 10, 2013
Association of myeloid-derived suppressor cells and efficacy of cytokine-induced killer cell immunotherapy in metastatic renal cell carcinoma patientsZibing Wang, Yong Zhang, Yuqing Liu, et al.
British Journal of Haematology|April 30, 2020
Addition of low-dose decitabine to bortezomib and dexamethasone as second-line therapy in multiple myelomaNing Li, Lina Liu, Pu Xiang, et al.
Frontiers in Immunology|October 10, 2022
Decreased TCF1 and BCL11B expression predicts poor prognosis for patients with chronic lymphocytic leukemiaTaotao Liang, Xiaojiao Wang, Yanyan Liu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|April 21, 2016
[Primary renal lymphoma with the initial symptom of nephrotic syndrome: a case report]Yuanji Li, Wenjia Wang, Yufu Li, et al.
International Journal of Clinical and Experimental Pathology|January 23, 2020
DDX51 gene promotes proliferation by activating Wnt/β-catenin signaling in breast cancerWeibo Sun, Shundong Cang, Xiaodong Lv, et al.
Oncotarget|April 21, 2017
Loss of thyroid hormone receptor interactor 13 inhibits cell proliferation and survival in human chronic lymphocytic leukemiaKeshu Zhou, Wentao Zhang, Qing Zhang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|February 3, 2015
[Efficacy analysis of CHAG priming regimen as induction therapy for newly diagnosed acute myelogenous leukemia]Qianmeng Hao, Xudong Wei, Qingsong Yin, et al.
Chinese Medical Journal|February 28, 2014
Twelve years' experience and clinical results of using the radial artery for coronary revascularizationZhaoyun Cheng, Ziniu Zhao, Xiaoqiang Quan, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|April 21, 2016
[Efficacy analysis of CAG priming regimen combined with talidomide, interferon and interleukin 2 as the induction therapy for relapsed refractory acute myeloid leukemia]Yingling Zu, Yanli Zhang, Jian Zhou, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|February 3, 2015
[One case of Rosai-Dorfman disease]Ke Feng, Hu Zhou, Jingyi Yang, et al.
Pageof 26

Showing results (141-150 of 252) with videos related to

Sort By:
Pageof 26
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 10, 2013
Association of myeloid-derived suppressor cells and efficacy of cytokine-induced killer cell immunotherapy in metastatic renal cell carcinoma patientsZibing Wang, Yong Zhang, Yuqing Liu, et al.
British Journal of Haematology|April 30, 2020
Addition of low-dose decitabine to bortezomib and dexamethasone as second-line therapy in multiple myelomaNing Li, Lina Liu, Pu Xiang, et al.
Frontiers in Immunology|October 10, 2022
Decreased TCF1 and BCL11B expression predicts poor prognosis for patients with chronic lymphocytic leukemiaTaotao Liang, Xiaojiao Wang, Yanyan Liu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|April 21, 2016
[Primary renal lymphoma with the initial symptom of nephrotic syndrome: a case report]Yuanji Li, Wenjia Wang, Yufu Li, et al.
International Journal of Clinical and Experimental Pathology|January 23, 2020
DDX51 gene promotes proliferation by activating Wnt/β-catenin signaling in breast cancerWeibo Sun, Shundong Cang, Xiaodong Lv, et al.
Oncotarget|April 21, 2017
Loss of thyroid hormone receptor interactor 13 inhibits cell proliferation and survival in human chronic lymphocytic leukemiaKeshu Zhou, Wentao Zhang, Qing Zhang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|February 3, 2015
[Efficacy analysis of CHAG priming regimen as induction therapy for newly diagnosed acute myelogenous leukemia]Qianmeng Hao, Xudong Wei, Qingsong Yin, et al.
Chinese Medical Journal|February 28, 2014
Twelve years' experience and clinical results of using the radial artery for coronary revascularizationZhaoyun Cheng, Ziniu Zhao, Xiaoqiang Quan, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|April 21, 2016
[Efficacy analysis of CAG priming regimen combined with talidomide, interferon and interleukin 2 as the induction therapy for relapsed refractory acute myeloid leukemia]Yingling Zu, Yanli Zhang, Jian Zhou, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|February 3, 2015
[One case of Rosai-Dorfman disease]Ke Feng, Hu Zhou, Jingyi Yang, et al.
Pageof 26